Ullal City Municipal Council bypoll: Congress candidates win both seats

[email protected] (CD Network)
February 15, 2017

Mangaluru, Feb 15: In spite of rigorous pre-poll campaign by Bharatiya Janata Party candidates, the Congress candidates have managed to register huge victories in two wards of Ullal City Municipal Council.

congressThe bypolls were held in Chembugudde and Kallapu wards of the CMC on February 12 and the results were announced today.

Sitting Congress councillor Basil D'Souza retained Chembugudde ward by defeating his closest rival Satish Chembugudde of BJP by a huge margin.

884 out of 1,520 voters had cast their votes in the ward. While D’Soza bagged 600 votes, Satish secured only 149 votes. Harish Shetty of CPM candidate managed to get only 78 votes. Kalandar, an independent candidate, finished fourth by bagging 57 votes.

In Kallapu ward, Congress candidate Usman Kallapu secured 510 votes out of 1005 votes. His closest rival was Dinakar Ullal , an independent candidate, who bagged 240 votes. BJP candidate Chandrahas Pandithouse bagged 226 votes. Ismail Shaffi of JD(S) secured only 29 votes.

Interestingly, women voters outnumbered their male counterparts in both wards.

Comments

SYED
 - 
Thursday, 16 Feb 2017

Mr. Narenanna, This is Anti Nationalists Sanghis infested area so BJP will loose obviously ...hehehehehe

Rikaz
 - 
Wednesday, 15 Feb 2017

BJP has a corrupt president in states....doubtful to win any seats...if he would win his own seat in Karnataka...that will be great job....

Naren kotian
 - 
Wednesday, 15 Feb 2017

this is jihadi infested area so khangrace will win obviously

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
August 7,2020

Udupi, Aug 6: Three people including police personnel entered a well and rescued an elderly woman who had accidentally fallen into Udupi on Thursday.

A police sub-inspector and two others got down into a well and rescued the elderly woman, who accidentally fell into well at near her home at Kukkikatte.

The locals immediately alerted to police and fire and rescue personal.

Udupi town police sub-inspector Sadashiva Govroji, fire and rescue staff Vinayaka and a local Auto-driver Rajesh Nayak got into the well and brought the woman out safely.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 2,2020

Bengaluru, Jul 2: Senior Congress leader Mallikarjun Kharge said that the "RSS needs to be defeated to save the country" and Prime Minister Narendra Modi and Union Home Minister Amit Shah are "destroying the nation".

Kharge was speaking at a KPCC program where DK Shivakumar took charge as state Congress president.

He said that the Prime Minister and the Home Minister are not ready to take accountability for any issues including China, and are instead blaming Rajiv Gandhi Foundation of getting funds from China.

"Rajiv Gandhi foundation utilized funds for the development of the nation and for the betterment of the downtrodden people," Kharge said.

"Prime Minister Modi and Shah both are destroying the economy of the nation, and their policies and plans are the reason for increasing COVID-19 situation in India," he said.

"Prime Minister and Amit Shah never listen to Opposition parties, instead they plan something and their policies are the reason for MSME losses and job losses in the country," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.